
Haemonetics Corporation
Haemonetics Corporation(HAE)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · HAE · 截至 2026年6月8日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Haemonetics Corporation内部人在过去近12个月净买入股份,可能反映对公司前景的信心。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
HAE 季度内部人买卖趋势
HAE 内幕交易卖出 · HAE 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · HAE CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
HAE 高管卖出股份 · HAE 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 15, 2026 | Basil Michelle L EVP and General Counsel | Award | 28,424 | — | Form 4 |
| May 15, 2026 | Basil Michelle L EVP and General Counsel | Other | 2,913 | $164K | Form 4 |
| May 15, 2026 | Chan Frank EVP, Chief Operating Officer | Award | 27,535 | — | Form 4 |
| May 15, 2026 | Chan Frank EVP, Chief Operating Officer | Other | 546 | $31K | Form 4 |
| May 15, 2026 | DArecca James EVP, Chief Financial Officer | Award | 29,312 | — | Form 4 |
| May 15, 2026 | DArecca James EVP, Chief Financial Officer | Other | 2,505 | $141K | Form 4 |
| May 15, 2026 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Award | 2,220 | — | Form 4 |
| May 15, 2026 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Other | 197 | $11K | Form 4 |
| May 15, 2026 | Galvin Roy EVP, Chief Commercial Officer | Award | 27,535 | — | Form 4 |
| May 15, 2026 | Galvin Roy EVP, Chief Commercial Officer | Other | 879 | $49K | Form 4 |
| May 15, 2026 | Miller Laurie A. SVP, Human Resources | Award | 13,323 | — | Form 4 |
| May 15, 2026 | Miller Laurie A. SVP, Human Resources | Other | 948 | $53K | Form 4 |
| May 15, 2026 | Simon, Christopher President & CEO · Director | Award | 78,344 | — | Form 4 |
| May 15, 2026 | Simon, Christopher President & CEO · Director | Other | 9,681 | $545K | Form 4 |
| May 1, 2026 | DArecca James EVP, Chief Financial Officer | Other | 655 | $39K | Form 4 |
| Nov 10, 2025 | KROLL MARK W Director | Purchase | 1,400 | $99K | Form 4 |
| Oct 31, 2025 | Galvin Roy EVP, Chief Commercial Officer | Other | 145 | $7K | Form 4 |
| Sep 17, 2025 | Miller Laurie A. SVP, Human Resources | Other | 238 | $12K | Form 4 |
| Jul 24, 2025 | Zane Ellen M Director | Award | 2,693 | — | Form 4 |
| Jul 24, 2025 | Pomeroy Claire Director | Award | 2,693 | — | Form 4 |
| Jul 24, 2025 | KROLL MARK W Director | Award | 2,693 | — | Form 4 |
| Jul 24, 2025 | Johnson Lloyd Emerson Director | Award | 2,693 | — | Form 4 |
| Jul 24, 2025 | Dockendorff Charles J Director | Award | 2,693 | — | Form 4 |
| Jul 24, 2025 | COYLE MICHAEL J Director | Award | 2,693 | — | Form 4 |
| Jul 24, 2025 | Bryant Diane M Director | Award | 2,693 | — | Form 4 |
Maunsell Farris Maryanne
VP, Chief Accounting Officer
日期
May 15
股数
2,220
均价
—
总金额
—
Maunsell Farris Maryanne
VP, Chief Accounting Officer
日期
May 15
股数
197
均价
$56.29
总金额
$11K
Simon, Christopher
President & CEO · Director
日期
May 15
股数
9,681
均价
$56.29
总金额
$545K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 HAE 内幕交易
HAE 内幕交易
Haemonetics Corporation(HAE)内幕交易数据来源于公司内部人(包括DArecca James (EVP, Chief Financial Officer), Galvin Roy (EVP, Chief Commercial Officer), Miller Laurie A. (SVP, Human Resources))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。HAE内部人近期主要在买入,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Haemonetics Corporation机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
HAE 内幕交易 · 5个问题Haemonetics Corporation(HAE)的内部人包括高管和董事,如DArecca James (EVP, Chief Financial Officer), Galvin Roy (EVP, Chief Commercial Officer), Miller Laurie A. (SVP, Human Resources)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026